APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ophthalmic Medicine Market Outlook and Growth Opportunities 2026

Report ID 17401914042 January 2026191 pages

Choose your research edition.

Industry ResearchOphthalmic Medicine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Medicine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Ophthalmic Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Medicine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ophthalmic Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ophthalmic Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ophthalmic Medicine market include Zhejiang Shapuaisi Pharmaceutical, Shenyang Xingqi Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Novaliq, Mentholatum, Bausch Health and Alcon NV, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmic Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Medicine Segment by Company

Zhejiang Shapuaisi Pharmaceutical

Shenyang Xingqi Pharmaceutical Co.,Ltd.

Chengdu Kanghong Pharmaceutical Group

Santen Pharmaceutica

Novaliq

Mentholatum

Bausch Health

Alcon NV

Ophthalmic Medicine Segment by Type

Eye Drops

Gelling Agent

Tablet

Eye Ointment

Injection

Ophthalmic Medicine Segment by Application

Cataract

Anti-infective

Anti-fatigue and Dryness

Ophthalmic Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ophthalmic Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ophthalmic Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ophthalmic Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Ophthalmic Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmic Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ophthalmic Medicine industry.

Chapter 3: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ophthalmic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ophthalmic Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic Medicine Industry Trends Table 2. Ophthalmic Medicine Industry Drivers Table 3. Ophthalmic Medicine Industry Opportunities and Challenges Table 4. Ophthalmic Medicine Industry Restraints Table 5. Global Ophthalmic Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ophthalmic Medicine Revenue Share by Company (2021-2026) Table 7. Global Ophthalmic Medicine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ophthalmic Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Ophthalmic Medicine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ophthalmic Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ophthalmic Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Ophthalmic Medicine Company, Product Type & Application Table 13. Global Ophthalmic Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmic Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Eye Drops Table 18. Significant Companies of Gelling Agent Table 19. Significant Companies of Tablet Table 20. Significant Companies of Eye Ointment Table 21. Significant Companies of Injection Table 22. Global Ophthalmic Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Ophthalmic Medicine Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Ophthalmic Medicine Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Ophthalmic Medicine Sales Volume Share by Type (2021-2026) Table 26. Global Ophthalmic Medicine Sales Volume Share by Type (2027-2032) Table 27. Global Ophthalmic Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Ophthalmic Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Ophthalmic Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Ophthalmic Medicine Sales Value Share by Type (2021-2026) Table 31. Global Ophthalmic Medicine Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Cataract Table 33. Significant Companies of Anti-infective Table 34. Significant Companies of Anti-fatigue and Dryness Table 35. Global Ophthalmic Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Ophthalmic Medicine Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Ophthalmic Medicine Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Ophthalmic Medicine Sales Volume Share by Application (2021-2026) Table 39. Global Ophthalmic Medicine Sales Volume Share by Application (2027-2032) Table 40. Global Ophthalmic Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Ophthalmic Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Ophthalmic Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Ophthalmic Medicine Sales Value Share by Application (2021-2026) Table 44. Global Ophthalmic Medicine Sales Value Share by Application (2027-2032) Table 45. Global Ophthalmic Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Ophthalmic Medicine Sales by Region (2021-2026) & (K Units) Table 47. Global Ophthalmic Medicine Sales Market Share by Region (2021-2026) Table 48. Global Ophthalmic Medicine Sales by Region (2027-2032) & (K Units) Table 49. Global Ophthalmic Medicine Sales Market Share by Region (2027-2032) Table 50. Global Ophthalmic Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Ophthalmic Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Ophthalmic Medicine Sales Value Share by Region (2021-2026) Table 53. Global Ophthalmic Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Ophthalmic Medicine Sales Value Share by Region (2027-2032) Table 55. Global Ophthalmic Medicine Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Ophthalmic Medicine Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Ophthalmic Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Ophthalmic Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 60. Global Ophthalmic Medicine Sales Market Share by Country (2021-2026) Table 61. Global Ophthalmic Medicine Sales by Country (2027-2032) & (K Units) Table 62. Global Ophthalmic Medicine Sales Market Share by Country (2027-2032) Table 63. Global Ophthalmic Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Ophthalmic Medicine Sales Value Market Share by Country (2021-2026) Table 65. Global Ophthalmic Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Ophthalmic Medicine Sales Value Market Share by Country (2027-2032) Table 67. Zhejiang Shapuaisi Pharmaceutical Company Information Table 68. Zhejiang Shapuaisi Pharmaceutical Business Overview Table 69. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio Table 71. Zhejiang Shapuaisi Pharmaceutical Recent Development Table 72. Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information Table 73. Shenyang Xingqi Pharmaceutical Co.,Ltd. Business Overview Table 74. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio Table 76. Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Development Table 77. Chengdu Kanghong Pharmaceutical Group Company Information Table 78. Chengdu Kanghong Pharmaceutical Group Business Overview Table 79. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio Table 81. Chengdu Kanghong Pharmaceutical Group Recent Development Table 82. Santen Pharmaceutica Company Information Table 83. Santen Pharmaceutica Business Overview Table 84. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Santen Pharmaceutica Ophthalmic Medicine Product Portfolio Table 86. Santen Pharmaceutica Recent Development Table 87. Novaliq Company Information Table 88. Novaliq Business Overview Table 89. Novaliq Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novaliq Ophthalmic Medicine Product Portfolio Table 91. Novaliq Recent Development Table 92. Mentholatum Company Information Table 93. Mentholatum Business Overview Table 94. Mentholatum Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Mentholatum Ophthalmic Medicine Product Portfolio Table 96. Mentholatum Recent Development Table 97. Bausch Health Company Information Table 98. Bausch Health Business Overview Table 99. Bausch Health Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bausch Health Ophthalmic Medicine Product Portfolio Table 101. Bausch Health Recent Development Table 102. Alcon NV Company Information Table 103. Alcon NV Business Overview Table 104. Alcon NV Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Alcon NV Ophthalmic Medicine Product Portfolio Table 106. Alcon NV Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Ophthalmic Medicine Distributors List Table 110. Ophthalmic Medicine Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Ophthalmic Medicine Product Image Figure 2. Global Ophthalmic Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Medicine Sales (2021-2032) & (K Units) Figure 5. Global Ophthalmic Medicine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ophthalmic Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Eye Drops Image Figure 10. Gelling Agent Image Figure 11. Tablet Image Figure 12. Eye Ointment Image Figure 13. Injection Image Figure 14. Global Ophthalmic Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Ophthalmic Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Ophthalmic Medicine Sales Volume Share by Type (2021-2032) Figure 17. Global Ophthalmic Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Ophthalmic Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Ophthalmic Medicine Sales Value Share by Type (2021-2032) Figure 20. Cataract Image Figure 21. Anti-infective Image Figure 22. Anti-fatigue and Dryness Image Figure 23. Global Ophthalmic Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Ophthalmic Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Ophthalmic Medicine Sales Volume Share by Application (2021-2032) Figure 26. Global Ophthalmic Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ophthalmic Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Ophthalmic Medicine Sales Value Share by Application (2021-2032) Figure 29. Global Ophthalmic Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Ophthalmic Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Ophthalmic Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Ophthalmic Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Ophthalmic Medicine Sales Value (2021-2032) & (US$ Million) Figure 34. North America Ophthalmic Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Ophthalmic Medicine Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Ophthalmic Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Ophthalmic Medicine Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Ophthalmic Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Ophthalmic Medicine Sales Value (2021-2032) & (US$ Million) Figure 40. South America Ophthalmic Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Ophthalmic Medicine Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Ophthalmic Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Ophthalmic Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Ophthalmic Medicine Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Ophthalmic Medicine Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Eye Drops
  • Gelling Agent
  • Tablet
  • Eye Ointment
  • Injection
Applications
  • Cataract
  • Anti-infective
  • Anti-fatigue and Dryness
Companies covered
  • Zhejiang Shapuaisi Pharmaceutical
  • Shenyang Xingqi Pharmaceutical Co.,Ltd.
  • Chengdu Kanghong Pharmaceutical Group
  • Santen Pharmaceutica
  • Novaliq
  • Mentholatum
  • Bausch Health
  • Alcon NV

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Ophthalmic Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Ophthalmic Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ophthalmic Medicine Market Dynamics
  1. 2.1 Ophthalmic Medicine Industry Trends
  2. 2.2 Ophthalmic Medicine Industry Drivers
  3. 2.3 Ophthalmic Medicine Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Medicine Industry Restraints
3 Ophthalmic Medicine Market by Company
  1. 3.1 Global Ophthalmic Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Ophthalmic Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Ophthalmic Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Ophthalmic Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Ophthalmic Medicine Company Ranking (2024-2026)
  6. 3.6 Global Ophthalmic Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Ophthalmic Medicine Company Product Type and Application
  8. 3.8 Global Ophthalmic Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ophthalmic Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ophthalmic Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ophthalmic Medicine Market by Type
  1. 4.1 Ophthalmic Medicine Type Introduction
  2. 4.1.1 Eye Drops
  3. 4.1.2 Gelling Agent
  4. 4.1.3 Tablet
  5. 4.1.4 Eye Ointment
  6. 4.1.5 Injection
  7. 4.2 Global Ophthalmic Medicine Sales Volume by Type
  8. 4.2.1 Global Ophthalmic Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Ophthalmic Medicine Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Ophthalmic Medicine Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Ophthalmic Medicine Sales Value by Type
  12. 4.3.1 Global Ophthalmic Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Ophthalmic Medicine Sales Value by Type (2021-2032)
  14. 4.3.3 Global Ophthalmic Medicine Sales Value Share by Type (2021-2032)
5 Ophthalmic Medicine Market by Application
  1. 5.1 Ophthalmic Medicine Application Introduction
  2. 5.1.1 Cataract
  3. 5.1.2 Anti-infective
  4. 5.1.3 Anti-fatigue and Dryness
  5. 5.2 Global Ophthalmic Medicine Sales Volume by Application
  6. 5.2.1 Global Ophthalmic Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ophthalmic Medicine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ophthalmic Medicine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ophthalmic Medicine Sales Value by Application
  10. 5.3.1 Global Ophthalmic Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ophthalmic Medicine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ophthalmic Medicine Sales Value Share by Application (2021-2032)
6 Ophthalmic Medicine Regional Sales and Value Analysis
  1. 6.1 Global Ophthalmic Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Ophthalmic Medicine Sales by Region (2027-2032)
  5. 6.3 Global Ophthalmic Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ophthalmic Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ophthalmic Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ophthalmic Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Ophthalmic Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ophthalmic Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Ophthalmic Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ophthalmic Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Ophthalmic Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ophthalmic Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ophthalmic Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ophthalmic Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Ophthalmic Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ophthalmic Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ophthalmic Medicine Sales Value Share by Country, 2025 VS 2032
7 Ophthalmic Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Ophthalmic Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ophthalmic Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ophthalmic Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Ophthalmic Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Ophthalmic Medicine Sales by Country (2027-2032)
  6. 7.4 Global Ophthalmic Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ophthalmic Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ophthalmic Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ophthalmic Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ophthalmic Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ophthalmic Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Shapuaisi Pharmaceutical
  2. 8.1.1 Zhejiang Shapuaisi Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Shapuaisi Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio
  6. 8.1.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments
  7. 8.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
  8. 8.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
  9. 8.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Business Overview
  10. 8.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio
  12. 8.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments
  13. 8.3 Chengdu Kanghong Pharmaceutical Group
  14. 8.3.1 Chengdu Kanghong Pharmaceutical Group Company Information
  15. 8.3.2 Chengdu Kanghong Pharmaceutical Group Business Overview
  16. 8.3.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio
  18. 8.3.5 Chengdu Kanghong Pharmaceutical Group Recent Developments
  19. 8.4 Santen Pharmaceutica
  20. 8.4.1 Santen Pharmaceutica Company Information
  21. 8.4.2 Santen Pharmaceutica Business Overview
  22. 8.4.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Santen Pharmaceutica Ophthalmic Medicine Product Portfolio
  24. 8.4.5 Santen Pharmaceutica Recent Developments
  25. 8.5 Novaliq
  26. 8.5.1 Novaliq Company Information
  27. 8.5.2 Novaliq Business Overview
  28. 8.5.3 Novaliq Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novaliq Ophthalmic Medicine Product Portfolio
  30. 8.5.5 Novaliq Recent Developments
  31. 8.6 Mentholatum
  32. 8.6.1 Mentholatum Company Information
  33. 8.6.2 Mentholatum Business Overview
  34. 8.6.3 Mentholatum Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mentholatum Ophthalmic Medicine Product Portfolio
  36. 8.6.5 Mentholatum Recent Developments
  37. 8.7 Bausch Health
  38. 8.7.1 Bausch Health Company Information
  39. 8.7.2 Bausch Health Business Overview
  40. 8.7.3 Bausch Health Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bausch Health Ophthalmic Medicine Product Portfolio
  42. 8.7.5 Bausch Health Recent Developments
  43. 8.8 Alcon NV
  44. 8.8.1 Alcon NV Company Information
  45. 8.8.2 Alcon NV Business Overview
  46. 8.8.3 Alcon NV Ophthalmic Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Alcon NV Ophthalmic Medicine Product Portfolio
  48. 8.8.5 Alcon NV Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmic Medicine Value Chain Analysis
  2. 9.1.1 Ophthalmic Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmic Medicine Sales Mode & Process
  6. 9.2 Ophthalmic Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmic Medicine Distributors
  9. 9.2.3 Ophthalmic Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst